A Study of Hemodialysis Arteriovenous Fistulae Stenosis Treated With APERTO
Evaluation of the Safety and Efficacy of the Paclitaxel Eluting Hemodialysis Shunt Balloon Dilatation Catheter (APERTO) in Treatment of Hemodialysis Arteriovenous Fistulae Stenosis: A Prospective, Multicenter, Randomized, Controlled Clinical Study
Sponsor: ZhuHai Cardionovum Medical Device Co., Ltd.
A NA clinical study on Fistula and Peripheral Arterial Disease, this trial is completed. The trial is conducted by ZhuHai Cardionovum Medical Device Co., Ltd. and has accumulated 9 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Sep 2019 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Dec 2018 — Sep 2019 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 4 earlier versions
-
Jun 2018 — Dec 2018 [monthly]
Recruiting NA
-
Jul 2017 — Jun 2018 [monthly]
Recruiting NA
-
Mar 2017 — Jul 2017 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
-
Jan 2017 — Mar 2017 [monthly]
Active Not Recruiting NA
First recorded
Oct 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- ZhuHai Cardionovum Medical Device Co., Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .